Inflammatory extracellular vesicles prompt heart dysfunction via TRL4-dependent NF-κB activation

Area of Science:

• Cardiovascular Biology
• Immunology
• Cell Biology

Background:

• Myocardial infarction (MI) triggers inflammation and cardiac remodeling via damage-associated proteins and macrophage infiltration.
• Circulating inflammatory extracellular vesicles (EVs) are key mediators in the progression of ischemia-induced inflammation.
• This study investigates the hypothesis that EVs exert direct cytotoxicity on cardiomyocytes.

Purpose of the Study:

• To determine if inhibiting inflammatory EV generation in early ischemia ameliorates cardiac outcomes.
• To evaluate the cytotoxic effects of EVs on cardiomyocytes both in vivo and in vitro.
• To elucidate the mechanisms by which inflammatory EVs induce cardiomyocyte death.

Main Methods:

• Rats with induced myocardial infarction were treated with an extracellular vesicle biogenesis inhibitor.
• Cardiac function was assessed using echocardiography and hemodynamic analysis.
• Ex vivo and in vitro experiments evaluated the cytotoxic effects of circulating EVs on cardiomyocytes, including NF-κB pathway analysis.

Main Results:

• Post-MI, circulating EVs increased significantly, carrying inflammatory alarmins.
• Inhibition of inflammatory EVs preserved left ventricular ejection fraction and improved cardiac contractility and relaxation.
• Post-infarction EVs induced greater cardiomyocyte death ex vivo compared to EVs from healthy rats, mediated by NF-κB nuclear translocation.

Conclusions:

• Circulating inflammatory EVs contribute to cardiomyocyte cytotoxicity after myocardial infarction.
• Targeting extracellular vesicles in the acute phase of MI shows therapeutic potential for preserving cardiac function.
• Inhibiting EV biogenesis may represent a novel strategy to mitigate ischemia-reperfusion injury.